Thromboembolism and resistance to activated protein C in children with underlying cardiac disease - 12/10/17
Abstract |
OBJECTIVES: In the majority of cases, resistance to activated protein C is caused by the point mutation Arg506 to Gln in the factor V gene and has emerged as the most important hereditary cause of thromboembolism. METHODS: To determine to what extent resistance to activated protein C was present in children with thromboembolism and underlying cardiac disease, its occurrence was retrospectively investigated. By using a method based on activated partial thromboplastin time, with DNA technique derived from the polymerase chain reaction, we investigated nine children with underlying cardiac disease in whom thromboembolism had previously occurred. RESULTS: Heterozygous Arg506-to-Gln mutation in the factor V gene was diagnosed in five of the nine children investigated. In addition, protein C type I deficiency w as found in three patients, and two of the nine children showed increased lipoprotein (a) plasma values. Risk factors were present in all children with symptoms. CONCLUSIONS: These data indicate that deficiencies in the protein C anticoagulant pathway are likely to play an important role in the early manifestation of thromboembolism in children with underlying cardiac disease. (J Pediatr 1996;129:677-9)
Le texte complet de cet article est disponible en PDF.Abbreviations : APC, Lp(a)
Plan
From the Departments of Paediatric Cardiology, Paediatrics, and Paediatric Haematology/Oncology, University Hospital Münster, Germany |
|
Reprint requests: Ulrike Nowak-Göttl, MD, Westfälische Wilhelms-Universität, Paediatric Haematology and Oncology, Albert-Schweitzer Strasse 33, D-48149 Münster, Germany. |
|
0022-3476/96/$5.00 + 0 9/21/75545 |
Vol 129 - N° 5
P. 677-679 - novembre 1996 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?